Dotchin & Associates on Behalf of Emergent Biosolutions
Global life sciences company
Based in MD
🤖
AI Overview
With $0 in lobbying spend across 9 quarterly filings, Dotchin & Associates on Behalf of Emergent Biosolutions is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2020 to 2021.
$0
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $0 |
| 2021 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Disaster Planning, Budget/Appropriations, Homeland Security, Defense
- •FY 2021 appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures for the US government. National Defense Authorization Act
- •COVID 19 provisions
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.